Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The haem detoxification pathway in *Plasmodium falciparum* is a crucial process for neutralizing toxic free haem released during hemoglobin digestion. It involves the polymerization of haem into inert hemozoin crystals within the food vacuole of the parasite. The Heme Detoxification Protein (HDP/PfHDP) is a key enzyme in this pathway, catalyzing the conversion of free haem to hemozoin. This pathway is essential for parasite survival and is targeted by several antimalarial drugs, including chloroquine and artemisinins. The pathway's uniqueness to Plasmodium makes it an attractive drug target.
Inhibition of haem polymerization and hemozoin formation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Haem Detoxification Pathway (Plasmodium falciparum) (HDP).